Characteristics and Clinical Value of 18F-FDG PET/CT in the Management of Adult-Onset Still's Disease : 35 Cases
While the diagnosis of adult-onset Still's disease (AOSD) involves the exclusion of differential diagnoses, the characteristics and value of 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography coupled with CT (PET/CT) in the management of AOSD remain poorly known. Our retrospective study included patients from four centers, fulfilling Yamaguchi or Fautrel criteria, who underwent a PET/CT during an active AOSD. Thirty-five patients were included. At the time of PET/CT, the Yamaguchi criteria were met in 23 of 29 evaluable cases. PET/CT showed bone marrow (74.3%), lymph node (74.3%), and splenic (48.6%) FDG uptake. Despite arthralgia or arthritis in most patients, joints were rarely the sites of 18F-FDG accumulation. The spatial distribution of 18F-FDG uptake was nonspecific, and its intensity could be similar to malignant disease. Lymph node or bone marrow biopsy was performed after PET/CT in 20 patients (57.1%). The intensity of bone marrow; splenic and lymph node hypermetabolism appeared to be correlated with disease activity. Abnormal PET/CT in the cervical lymph nodes and age ≥ 60 years seemed to be predictive factors for monocyclic evolution. The clinical value of PET/CT is not in direct diagnosis; but as an aid in excluding differential diagnoses by searching for their scintigraphic features and guiding biopsy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
Journal of clinical medicine - 10(2021), 11 vom: 04. Juni |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Brisset, Josselin [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 05.07.2021 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/jcm10112489 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM327465646 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM327465646 | ||
003 | DE-627 | ||
005 | 20231225200838.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/jcm10112489 |2 doi | |
028 | 5 | 2 | |a pubmed24n1091.xml |
035 | |a (DE-627)NLM327465646 | ||
035 | |a (NLM)34199846 | ||
035 | |a (PII)2489 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Brisset, Josselin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Characteristics and Clinical Value of 18F-FDG PET/CT in the Management of Adult-Onset Still's Disease |b 35 Cases |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 05.07.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a While the diagnosis of adult-onset Still's disease (AOSD) involves the exclusion of differential diagnoses, the characteristics and value of 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography coupled with CT (PET/CT) in the management of AOSD remain poorly known. Our retrospective study included patients from four centers, fulfilling Yamaguchi or Fautrel criteria, who underwent a PET/CT during an active AOSD. Thirty-five patients were included. At the time of PET/CT, the Yamaguchi criteria were met in 23 of 29 evaluable cases. PET/CT showed bone marrow (74.3%), lymph node (74.3%), and splenic (48.6%) FDG uptake. Despite arthralgia or arthritis in most patients, joints were rarely the sites of 18F-FDG accumulation. The spatial distribution of 18F-FDG uptake was nonspecific, and its intensity could be similar to malignant disease. Lymph node or bone marrow biopsy was performed after PET/CT in 20 patients (57.1%). The intensity of bone marrow; splenic and lymph node hypermetabolism appeared to be correlated with disease activity. Abnormal PET/CT in the cervical lymph nodes and age ≥ 60 years seemed to be predictive factors for monocyclic evolution. The clinical value of PET/CT is not in direct diagnosis; but as an aid in excluding differential diagnoses by searching for their scintigraphic features and guiding biopsy | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a 18F-FDG PET/CT | |
650 | 4 | |a adult-onset Still’s disease | |
700 | 1 | |a Jamilloux, Yvan |e verfasserin |4 aut | |
700 | 1 | |a Dumonteil, Stephanie |e verfasserin |4 aut | |
700 | 1 | |a Lades, Guillaume |e verfasserin |4 aut | |
700 | 1 | |a Killian, Martin |e verfasserin |4 aut | |
700 | 1 | |a Gerfaud-Valentin, Mathieu |e verfasserin |4 aut | |
700 | 1 | |a Lemaire, Anne |e verfasserin |4 aut | |
700 | 1 | |a Chroboczek, Tomasz |e verfasserin |4 aut | |
700 | 1 | |a Liozon, Eric |e verfasserin |4 aut | |
700 | 1 | |a Gondran, Guillaume |e verfasserin |4 aut | |
700 | 1 | |a Sève, Pascal |e verfasserin |4 aut | |
700 | 1 | |a Monteil, Jacques |e verfasserin |4 aut | |
700 | 1 | |a Fauchais, Anne-Laure |e verfasserin |4 aut | |
700 | 1 | |a Ly, Kim Heang |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of clinical medicine |d 2012 |g 10(2021), 11 vom: 04. Juni |w (DE-627)NLM230666310 |x 2077-0383 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2021 |g number:11 |g day:04 |g month:06 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/jcm10112489 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 10 |j 2021 |e 11 |b 04 |c 06 |